俊文寶石(08351.HK)附屬遭債權人提清盤呈請 續停牌
俊文寶石(08351.HK)公布,公司之全資附屬東方紅食品收到債權人順發出口行呈請對其進行清盤之呈請。於去年12月28日,該附屬應付債權人的總金額連同利息為236.6萬元。
公司指,正在與債權人就還款條款及撤銷清盤呈請進行談判。該附屬的業務為採購及轉售中國藥品及健康食品予公司之其他附屬。於去年6月30日,該附屬的總資產佔公司及其附屬總資產約10.4%。
應公司之要求,公司股份已自去年8月17日起於聯交所暫停買賣,而有關買賣將繼續暫停,直至另行通知為止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.